An outline for a cost-effectiveness analysis of a drug for patients with Alzheimer's disease

PharmacoEconomics

Volumn 13, Issue 1, 1998, Pages 21-34

  Busschbach, Jan J ^a   Brouwer, W B ^a   van der Donk, A ^a   Passchier, J ^a   Rutten, F F ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; CAREGIVER; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DRUG COST; ECONOMIC EVALUATION; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

ALZHEIMER DISEASE; COST-BENEFIT ANALYSIS; DRUG COSTS; HUMANS; QUALITY OF LIFE;

EID: 0031983106     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199813010-00003     Document Type: Article

References (1)

1. Gold, MR, Siegel JE, Russell LB, et al., editors. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996